The multifaceted interplay between lipids and epigenetics. Issue 3 (June 2016)

• Record Type: Journal Article
• Authors: Dekkers, Koen F.; Slagboom, P. Eline; Jukema, J. Wouter; Heijmans, Bastiaan T.
• Is Part Of: Current opinion in lipidology. Volume 27:Issue 3(2016:Jun.)
• Publication Date: 2016-06
• Subjects: causal inference -- epigenetics -- integrative genomics -- lipids; Lipids -- Periodicals; 572.574
• DOI: 10.1097/MOL.0000000000000301
• Languages: English
• ISSNs: 1473-6535

Abstract

Abstract : Purpose of review: The interplay between lipids and epigenetic mechanisms has recently gained increased interest because of its relevance for common diseases and most notably atherosclerosis. This review discusses recent advances in unravelling this interplay with a particular focus on promising approaches and methods that will be able to establish causal relationships. Recent findings: Complementary approaches uncovered close links between circulating lipids and epigenetic mechanisms at multiple levels. A characterization of lipid-associated genetic variants suggests that these variants exert their influence on lipid levels through epigenetic changes in the liver. Moreover, exposure of monocytes to lipids persistently alters their epigenetic makeup resulting in more proinflammatory cells. Hence, epigenetic changes can both impact on and be induced by lipids. Summary: It is the combined application of technological advances to probe epigenetic modifications at a genome-wide scale and methodological advances aimed at causal inference (including Mendelian randomization and integrative genomics) that will elucidate the interplay between circulating lipids and epigenetics. Understanding its role in the development of atherosclerosis holds the promise of identifying a new category of therapeutic targets, since epigenetic changes are amenable to reversal.